The effect of B27 supplement on promoting in vitro propagation of Her2/neu-transformed mammary tumorspheres

Journal of Biotech Research

Volumn 3, Issue 1, 2011, Pages 7-18

  Gu, Yiben ^a   Fu, Jie ^a   Lo, Pang Kuo ^a   Wang, Shunqi ^a   Wang, Qian ^a   Chen, Hexin ^a  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER STEM CELLS; CELL POPULATIONS; CULTURE CONDITIONS; CULTURE MEDIUM; ESSENTIAL COMPONENT; GROWTH FACTOR; HIERARCHICAL ORGANIZATIONS; HUMAN BREAST CANCER; IN-VITRO; MODEL SYSTEM; MOUSE MAMMARY TUMOR VIRUS; SOLID TUMORS; TRANSGENIC MICE; TUMOR CELLS; TUMOR FORMATION;

CELL PROLIFERATION; DISEASES; MAMMALS; ONCOGENIC VIRUSES; PLANTS (BOTANY); SPHERES; STEM CELLS; TUMORS;

CELL CULTURE;

MOUSE MAMMARY TUMOR VIRUS; MUS; MUS MUSCULUS;

EID: 80051994208     PISSN: 19443285     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Visvader JE, Lindeman GJ: Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 2008, 8(10):755-768.
2. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF: Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 2003, 100(7):3983-3988.
3. Klonisch T, Wiechec E, Hombach-Klonisch S, Ande SR, Wesselborg S, Schulze-Osthoff K, Los M: Cancer stem cell markers in common cancers - therapeutic implications. Trends Mol Med 2008, 14(10):450-460.
4. Hennighausen L, Robinson GW: Signaling pathways in mammary gland development. Dev Cell 2001, 1(4):467-475.
5. Liu JC, Deng T, Lehal RS, Kim J, Zacksenhaus E: Identification of tumorsphere- and tumor-initiating cells in HER2/Neu-induced mammary tumors. Cancer Res 2007, 67(18):8671-8681.
6. Hung MC, Lau YK: Basic science of HER-2/neu: a review. Semin Oncol 1999, 26(4 Suppl 12):51-59.
7. Korkaya H, Paulson A, Iovino F, Wicha MS: HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion. Oncogene 2008, 27(47):6120-6130.
8. Yarden Y: Biology of HER2 and its importance in breast cancer. Oncology 2001, 61 Suppl 2:1-13.
9. Ross JS, Fletcher JA: The HER-2/neu Oncogene in Breast Cancer: Prognostic Factor, Predictive Factor, and Target for Therapy. Oncologist 1998, 3(4):237-252.
10. Reya T, Morrison SJ, Clarke MF, Weissman IL: Stem cells, cancer, and cancer stem cells. Nature 2001, 414(6859):105-111.
11. Lobo NA, Shimono Y, Qian D, Clarke MF: The biology of cancer stem cells. Annu Rev Cell Dev Biol 2007, 23:675-699.
12. Pontier SM, Muller WJ: Integrins in mammary-stem-cell biology and breast-cancer progression--a role in cancer stem cells? J Cell Sci 2009, 122(Pt 2):207-214
13. Dontu G, Al-Hajj M, Abdallah WM, Clarke MF, Wicha MS: Stem cells in normal breast development and breast cancer. Cell Prolif 2003, 36 Suppl 1:59-72.
14. Tsai RY: A molecular view of stem cell and cancer cell self-renewal. Int J Biochem Cell Biol 2004, 36(4):684-694.
15. Bapat SA: Evolution of cancer stem cells. Semin Cancer Biol 2007, 17(3):204-213.
16. Jordan CT, Guzman ML, Noble M: Cancer stem cells. N Engl J Med 2006, 355(12):1253-1261.
17. Wicha MS, Liu S, Dontu G: Cancer stem cells: an old idea--a paradigm shift. Cancer Res 2006, 66(4):1883-1890; discussion 1895-1886.
18. Pardal R, Clarke MF, Morrison SJ: Applying the principles of stem-cell biology to cancer. Nat Rev Cancer 2003, 3(12):895-902.
19. Bonnet D, Dick JE: Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997, 3(7):730-737.
20. Dontu G, Abdallah WM, Foley JM, Jackson KW, Clarke MF, Kawamura MJ, Wicha MS: In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 2003, 17(10):1253-1270.
21. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, Dirks PB: Identification of a cancer stem cell in human brain tumors. Cancer Res 2003, 63(18):5821-5828.
22. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, Dirks PB: Identification of human brain tumour initiating cells. Nature 2004, 432(7015):396-401.
23. Fang D, Nguyen TK, Leishear K, Finko R, Kulp AN, Hotz S, Van Belle PA, Xu X, Elder DE, Herlyn M: A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res 2005, 65(20):9328-9337.
24. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ: Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 2005, 65(23):10946-10951.
25. O'Brien CA, Pollett A, Gallinger S, Dick JE: A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007, 445(7123):106-110.
26. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, De Maria R: Identification and expansion of human colon-cancer-initiating cells. Nature 2007, 445(7123):111-115.
27. Li C, Heidt DG, Dalerba P, Burant CF, Zhang L, Adsay V, Wicha M, Clarke MF, Simeone DM: Identification of pancreatic cancer stem cells. Cancer Res 2007, 67(3):1030-1037.
28. Eramo A, Lotti F, Sette G, Pilozzi E, Biffoni M, Di Virgilio A, Conticello C, Ruco L, Peschle C, De Maria R: Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ 2008, 15(3):504-514.
29. Ponti D, Costa A, Zaffaroni N, Pratesi G, Petrangolini G, Coradini D, Pilotti S, Pierotti MA, Daidone MG: Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res 2005, 65(13):5506-5511.
30. Grange C, Lanzardo S, Cavallo F, Camussi G, Bussolati B: Sca-1 identifies the tumor-initiating cells in mammary tumors of BALB-neuT transgenic mice. Neoplasia 2008, 10(12):1433-1443.
31. Cariati M, Naderi A, Brown JP, Smalley MJ, Pinder SE, Caldas C, Purushotham AD: Alpha-6 integrin is necessary for the tumourigenicity of a stem cell-like subpopulation within the MCF7 breast cancer cell line. Int J Cancer 2008, 122(2):298-304.
32. Engelmann K, Shen H, Finn OJ: MCF7 side population cells with characteristics of cancer stem/progenitor cells express the tumor antigen MUC1. Cancer Res 2008, 68(7):2419-2426.
33. Dey D, Saxena M, Paranjape AN, Krishnan V, Giraddi R, Kumar MV, Mukherjee G, Rangarajan A: Phenotypic and functional characterization of human mammary stem/progenitor cells in long term culture. PLoS ONE 2009, 4(4):e5329.
34. Svendsen CN, Fawcett JW, Bentlage C, Dunnett SB: Increased survival of rat EGF-generated CNS precursor cells using B27 supplemented medium. Exp Brain Res 1995, 102(3):407-414.
35. Huang MZ, Zhang FC, Zhang YY: [Influence factors on the formation of mammospheres from breast cancer stem cells]. Beijing Da Xue Xue Bao 2008, 40(5):500-504.
36. Reynolds BA, Weiss S: Clonal and population analyses demonstrate that an EGF-responsive mammalian embryonic CNS precursor is a stem cell. Dev Biol 1996, 175(1):1-13.
37. Weiss S, Reynolds BA, Vescovi AL, Morshead C, Craig CG, van der Kooy D: Is there a neural stem cell in the mammalian forebrain? Trends Neurosci 1996, 19(9):387-393
38. Blau HM, Brazelton TR, Weimann JM: The evolving concept of a stem cell: entity or function? Cell 2001, 105(7):829-841
39. Brewer GJ, Torricelli JR, Evege EK, Price PJ: Optimized survival of hippocampal neurons in B27-supplemented Neurobasal, a new serum-free medium combination. J Neurosci Res 1993, 35(5):567-576.
40. Chen H, Rubin E, Zhang H, Chung S, Jie CC, Garrett E, Biswal S, Sukumar S: Identification of transcriptional targets of HOXA5. The Journal of biological chemistry 2005, 280(19):19373-19380.